ESR1 and breast carcinoma: Notably, despite the low expression of ESR1 (Supplementary Fig. 22), the estrogen response pathway still showed significant enrichment in tumor regions (Supplementary Fig. 24), emphasizing the power of pathway-based analyses to refine breast cancer classification.